Company details
Address
17 F., No. 277, Songren Rd.,
Xinyi Dist., Taipei City 11046,
Taiwan
17 F., No. 277, Songren Rd., Xinyi Dist., Taipei City 11046, Taiwan
Industry
Biotechnology and medical industry
生技醫療業
Vision
Provide better, safer, and more
affordable medicines to
patients worldwide.
提供全球病患更好、
更安全並更負擔得起的藥物
Provide better, safer, and more affordable medicines to patients worldwide.
提供全球病患更好、更安全並更負擔得起的藥物
Head Count
780
Website
Explore opportunities with us!
Founded in 1966, Lotus is international pharmaceutical company with global presence, focused on commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. The Company invests in diversified best portfolio consisting of high-barrier oncology, complex generics as well as 505(b)2 and NCE via internal R&D investment and licensing-in partnership, and also strengthens its portfolio competitiveness by adding biosimilar products with support from strategic partners. Its industry-leading infrastructure certified by most of the advanced regulatory authorities around the world, including US FDA, EU EMA, Japan PMDA, China FDA, and Brazil ANVISA.
Lotus provides a compatible compensation system to attract and retain talents, design a variety of rewards and motivating projects to give the employees the recognition they deserve. Despite that, Lotus also invests in and plan talent training and development programs and establish a healthy workforce with diversity and equity. And we have a variety of benefits and activities to keep employees a work-life balance.
Lotus values gender equality and racial diversity. In Taiwan, 48% leadership team members are females, and 8% white collar employees are foreigners and come from 13 countries with different cultural backgrounds.
Lotus is committed to and continues to strive to create a corporate culture and environment that attracts talent, build a better and more friendly workplace, provide a platform for employees’ sustainable development, and enable employees and the company to grow together.
美時化學製藥成立於1966年,目前為台灣營收規模最大的製藥公司,也是一家全球性的製藥公司。美時專注於新藥和學名藥的商業化,致力爲患者提供更好、更安全、更易取得的藥品。公司通過內部研發投資和合作授權,投資高門檻的腫瘤用藥、複雜學名藥以及505(b)2和NCE組成的多元化最佳產品組合,並透過戰略合作夥伴的支持下加強生物相似藥產品,以加强其產品組合競爭力。美時有亞洲地區最頂尖的研發中心與生產設備,也是台灣唯一同時獲得美國FDA、歐盟EMA、日本PMDA、中國FDA、及巴西ANVISA認證的藥廠。
美時重視性別平等和種族多元,提供包容與尊重的職場環境。在台灣,有48%的高階主管為女性,有8%的白領員工為外籍員工,他們來自13個不同的國家和文化背景。
美時堅持並繼續努力營造吸引人才的企業文化和環境,建立更好、更友善的職場,提供員工可持續發展的舞台,讓員工與公司共同成長。
Lotus provides a compatible compensation system to attract and retain talents, design a variety of rewards and motivating projects to give the employees the recognition they deserve. Despite that, Lotus also invests in and plan talent training and development programs and establish a healthy workforce with diversity and equity. And we have a variety of benefits and activities to keep employees a work-life balance.
Lotus values gender equality and racial diversity. In Taiwan, 48% leadership team members are females, and 8% white collar employees are foreigners and come from 13 countries with different cultural backgrounds.
Lotus is committed to and continues to strive to create a corporate culture and environment that attracts talent, build a better and more friendly workplace, provide a platform for employees’ sustainable development, and enable employees and the company to grow together.
美時化學製藥成立於1966年,目前為台灣營收規模最大的製藥公司,也是一家全球性的製藥公司。美時專注於新藥和學名藥的商業化,致力爲患者提供更好、更安全、更易取得的藥品。公司通過內部研發投資和合作授權,投資高門檻的腫瘤用藥、複雜學名藥以及505(b)2和NCE組成的多元化最佳產品組合,並透過戰略合作夥伴的支持下加強生物相似藥產品,以加强其產品組合競爭力。美時有亞洲地區最頂尖的研發中心與生產設備,也是台灣唯一同時獲得美國FDA、歐盟EMA、日本PMDA、中國FDA、及巴西ANVISA認證的藥廠。
友善職場 多元平等共融
美時提供具有競爭力的薪資獎酬制度吸引及保留人才、設計多樣化的獎酬與激勵方案認可員工的貢獻、投資與規劃各項人才訓練發展專案、營造多元平等包容且健康的就業環境、致力於提供讓員工工作生活平衡的各項福利與活動。美時重視性別平等和種族多元,提供包容與尊重的職場環境。在台灣,有48%的高階主管為女性,有8%的白領員工為外籍員工,他們來自13個不同的國家和文化背景。
美時堅持並繼續努力營造吸引人才的企業文化和環境,建立更好、更友善的職場,提供員工可持續發展的舞台,讓員工與公司共同成長。